Cargando…
Remote Monitoring in the Home Validates Clinical Gait Measures for Multiple Sclerosis
Background: The timed 25-foot walk (T25FW) is widely used as a clinic performance measure, but has yet to be directly validated against gait speed in the home environment. Objectives: To develop an accurate method for remote assessment of walking speed and to test how predictive the clinic T25FW is...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6053510/ https://www.ncbi.nlm.nih.gov/pubmed/30057565 http://dx.doi.org/10.3389/fneur.2018.00561 |
_version_ | 1783340838216007680 |
---|---|
author | Supratak, Akara Datta, Gourab Gafson, Arie R. Nicholas, Richard Guo, Yike Matthews, Paul M. |
author_facet | Supratak, Akara Datta, Gourab Gafson, Arie R. Nicholas, Richard Guo, Yike Matthews, Paul M. |
author_sort | Supratak, Akara |
collection | PubMed |
description | Background: The timed 25-foot walk (T25FW) is widely used as a clinic performance measure, but has yet to be directly validated against gait speed in the home environment. Objectives: To develop an accurate method for remote assessment of walking speed and to test how predictive the clinic T25FW is for real-life walking. Methods: An AX3-Axivity tri-axial accelerometer was positioned on 32 MS patients (Expanded Disability Status Scale [EDSS] 0–6) in the clinic, who subsequently wore it at home for up to 7 days. Gait speed was calculated from these data using both a model developed with healthy volunteers and individually personalized models generated from a machine learning algorithm. Results: The healthy volunteer model predicted gait speed poorly for more disabled people with MS. However, the accuracy of individually personalized models was high regardless of disability (R-value = 0.98, p-value = 1.85 × 10(−22)). With the latter, we confirmed that the clinic T25FW is strongly predictive of the maximum sustained gait speed in the home environment (R-value = 0.89, p-value = 4.34 × 10(−8)). Conclusion: Remote gait monitoring with individually personalized models is accurate for patients with MS. Using these models, we have directly validated the clinical meaningfulness (i.e., predictiveness) of the clinic T25FW for the first time. |
format | Online Article Text |
id | pubmed-6053510 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-60535102018-07-27 Remote Monitoring in the Home Validates Clinical Gait Measures for Multiple Sclerosis Supratak, Akara Datta, Gourab Gafson, Arie R. Nicholas, Richard Guo, Yike Matthews, Paul M. Front Neurol Neurology Background: The timed 25-foot walk (T25FW) is widely used as a clinic performance measure, but has yet to be directly validated against gait speed in the home environment. Objectives: To develop an accurate method for remote assessment of walking speed and to test how predictive the clinic T25FW is for real-life walking. Methods: An AX3-Axivity tri-axial accelerometer was positioned on 32 MS patients (Expanded Disability Status Scale [EDSS] 0–6) in the clinic, who subsequently wore it at home for up to 7 days. Gait speed was calculated from these data using both a model developed with healthy volunteers and individually personalized models generated from a machine learning algorithm. Results: The healthy volunteer model predicted gait speed poorly for more disabled people with MS. However, the accuracy of individually personalized models was high regardless of disability (R-value = 0.98, p-value = 1.85 × 10(−22)). With the latter, we confirmed that the clinic T25FW is strongly predictive of the maximum sustained gait speed in the home environment (R-value = 0.89, p-value = 4.34 × 10(−8)). Conclusion: Remote gait monitoring with individually personalized models is accurate for patients with MS. Using these models, we have directly validated the clinical meaningfulness (i.e., predictiveness) of the clinic T25FW for the first time. Frontiers Media S.A. 2018-07-13 /pmc/articles/PMC6053510/ /pubmed/30057565 http://dx.doi.org/10.3389/fneur.2018.00561 Text en Copyright © 2018 Supratak, Datta, Gafson, Nicholas, Guo and Matthews. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Neurology Supratak, Akara Datta, Gourab Gafson, Arie R. Nicholas, Richard Guo, Yike Matthews, Paul M. Remote Monitoring in the Home Validates Clinical Gait Measures for Multiple Sclerosis |
title | Remote Monitoring in the Home Validates Clinical Gait Measures for Multiple Sclerosis |
title_full | Remote Monitoring in the Home Validates Clinical Gait Measures for Multiple Sclerosis |
title_fullStr | Remote Monitoring in the Home Validates Clinical Gait Measures for Multiple Sclerosis |
title_full_unstemmed | Remote Monitoring in the Home Validates Clinical Gait Measures for Multiple Sclerosis |
title_short | Remote Monitoring in the Home Validates Clinical Gait Measures for Multiple Sclerosis |
title_sort | remote monitoring in the home validates clinical gait measures for multiple sclerosis |
topic | Neurology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6053510/ https://www.ncbi.nlm.nih.gov/pubmed/30057565 http://dx.doi.org/10.3389/fneur.2018.00561 |
work_keys_str_mv | AT supratakakara remotemonitoringinthehomevalidatesclinicalgaitmeasuresformultiplesclerosis AT dattagourab remotemonitoringinthehomevalidatesclinicalgaitmeasuresformultiplesclerosis AT gafsonarier remotemonitoringinthehomevalidatesclinicalgaitmeasuresformultiplesclerosis AT nicholasrichard remotemonitoringinthehomevalidatesclinicalgaitmeasuresformultiplesclerosis AT guoyike remotemonitoringinthehomevalidatesclinicalgaitmeasuresformultiplesclerosis AT matthewspaulm remotemonitoringinthehomevalidatesclinicalgaitmeasuresformultiplesclerosis |